Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic findings in monkey herpes virus could aid research in human cancer

01.10.2002


For the first time, scientists at the University of North Carolina at Chapel Hill have discovered similar gene activity profiles between a herpes virus that affects rhesus macaque monkeys and a human herpes virus linked to Kaposi’s sarcoma. This cancer is endemic among Mediterranean and sub-Sahara African populations. In the last 20 years, however, the disease has occurred most frequently in people with AIDS.



The study team, led by Dr. Blossom Damania, assistant professor of microbiology and immunology at UNC School of Medicine and a member of the Lineberger Comprehensive Cancer Center, also has identified three new genes in the rhesus monkey rhadinovirus that show high structural similarity to those in human herpesvirus-8, also known as Kaposi’s sarcoma-associated herpesvirus, or KSHV.

The new research, which appears in the Journal of Virology on Tuesday (Oct 1), lays the foundation for future studies using recombinant rhesus viruses that could eventually form the basis of targeted drug therapies against specific KSHV genes.


Researchers in microbial genetics use recombinant technology to study the effect of altered genes on the life cycle of viruses linked to human disease. These studies require large quantities of virus grown in tissue culture, which is a problem with the human virus, KSHV, because it cannot be cultured efficiently.

Damania said the simian virus can grow to very high titers in tissue culture and then grown in large quantities. These can be used in making recombinant viruses for testing in a rhesus macaque model.

"By developing this model, we can determine the genes that are important for virus survival, viral growth and replication, and genes that enable the virus to induce malignancies in its host. Once you’ve established the genes that are required to do all of these things, you can start thinking about developing drug therapies against these genes to prevent virus spread and to prevent the virus from inducing cancer in its host. So there is potential for developing at least two drug therapies at this point in time."

The scientific literature suggests that less than 10 percent of people in the Western Hemisphere are infected with KSHV; however, these percentages are currently under investigation. But around the Mediterranean, particularly Italy, Spain, Egypt and Greece, the percentage is between 25 percent and 40 percent.

And then there is sub-Saharan Africa, where the infected population is greater than 50 percent, Damania said. "The problem is very bad because of the HIV epidemic," Damania added. "It’s known that immune suppression is a factor. Whether you’re HIV-infected or a transplant patient taking immunosuppressive drugs or a patient undergoing chemotherapy, you are more likely to develop Kaposi’s sarcoma. In sub-Saharan Africa, many children 6 years of age develop Kaposi’s with very bad lesions. It’s the number one childhood cancer in this region primarily as a result of widespread HIV infection in the area."

KSHV is also associated with B-cell lymphomas, a type of blood cancer. "Although Kaposi’s sarcoma is the most common cancer linked to KSHV, many individuals frequently develop B-cell lymphomas, as well," Damania said.

"At the present time, most herpes viruses cannot be cured but their outbreak can be prevented. And so the best we can hope for at this point in time is an effective preventive strategy rather than a cure. Our research will help move us toward identifying potentially better therapies."

Leslie Lang | EurekAlert!

More articles from Health and Medicine:

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

nachricht Improving memory with magnets
28.03.2017 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Periodic ventilation keeps more pollen out than tilted-open windows

29.03.2017 | Health and Medicine

Researchers discover dust plays prominent role in nutrients of mountain forest ecoystems

29.03.2017 | Earth Sciences

OLED production facility from a single source

29.03.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>